全文获取类型
收费全文 | 22734篇 |
免费 | 849篇 |
国内免费 | 667篇 |
专业分类
耳鼻咽喉 | 38篇 |
儿科学 | 559篇 |
妇产科学 | 90篇 |
基础医学 | 1575篇 |
口腔科学 | 41篇 |
临床医学 | 2838篇 |
内科学 | 2108篇 |
皮肤病学 | 152篇 |
神经病学 | 159篇 |
特种医学 | 1326篇 |
外科学 | 7407篇 |
综合类 | 3664篇 |
预防医学 | 916篇 |
眼科学 | 8篇 |
药学 | 2027篇 |
15篇 | |
中国医学 | 503篇 |
肿瘤学 | 824篇 |
出版年
2023年 | 177篇 |
2022年 | 486篇 |
2021年 | 641篇 |
2020年 | 589篇 |
2019年 | 578篇 |
2018年 | 653篇 |
2017年 | 621篇 |
2016年 | 642篇 |
2015年 | 681篇 |
2014年 | 1521篇 |
2013年 | 1376篇 |
2012年 | 1348篇 |
2011年 | 1397篇 |
2010年 | 1184篇 |
2009年 | 1301篇 |
2008年 | 1253篇 |
2007年 | 1209篇 |
2006年 | 1094篇 |
2005年 | 971篇 |
2004年 | 759篇 |
2003年 | 659篇 |
2002年 | 502篇 |
2001年 | 462篇 |
2000年 | 417篇 |
1999年 | 319篇 |
1998年 | 314篇 |
1997年 | 252篇 |
1996年 | 236篇 |
1995年 | 261篇 |
1994年 | 238篇 |
1993年 | 188篇 |
1992年 | 222篇 |
1991年 | 171篇 |
1990年 | 164篇 |
1989年 | 138篇 |
1988年 | 183篇 |
1987年 | 120篇 |
1986年 | 87篇 |
1985年 | 86篇 |
1984年 | 83篇 |
1983年 | 36篇 |
1982年 | 84篇 |
1981年 | 73篇 |
1980年 | 88篇 |
1979年 | 65篇 |
1978年 | 50篇 |
1977年 | 50篇 |
1976年 | 51篇 |
1975年 | 29篇 |
1973年 | 38篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
阻塞性睡眠呼吸暂停综合征患者肾功能和心钠素的变化分析 总被引:3,自引:0,他引:3
目的探讨病人肾功能、心钠素(ANP)的含量变化及经鼻持续气道正压(nCPAP)治疗对阻塞性睡眠呼吸暂停综合征(OSAS)患者的影响。方法选择经多导睡眠图(PSG)确诊为中、重度的OSAS患者11例为试验组,PSG检查正常者14例为对照组,试验组给予nCPAP治疗,分别测定其血尿肌酐、尿量、尿β2-微球蛋白(β2-MG)、血浆心钠素(ANP),并计算出内生肌酐清除率(Ccr),比较试验组与对照组及试验组治疗前后各项指标的差异。结果试验组与对照组比较,Ccr,尿β2-MG差异无显著性,经nCPAP治疗后两指标也无明显改变;试验组的夜尿量、血ANP含量显著高于对照组,nCPAP治疗后上述指标均较治疗前明显下降。结论OSAS患者夜尿量增多可能与ANP增加有关,这种增高可以被nCPAP治疗所纠正。 相似文献
102.
目的探讨原位低温阻断肾血管肾实质切开取石术治疗复杂性肾结石的效果。方法2000年3月~2005年1月采用原位低温阻断肾血管肾实质切开取石术治疗肾内型肾盂复杂性肾结石患者22例,术中快速静脉滴注肌苷2.0g,静滴20%甘露醇250ml。根据术前影像检查结果及术中所见选择肾切口径路:13例充填于各盏的鹿角状结石,行肾背侧Brodt线肾实质肾盏切开取石;5例肾下盏肾盂鹿角状结石,行肾盂肾实质联合切开取石;4例结石过多者,于肾皮质最薄处另作放射状切口取石。结果肾血管阻断时间平均45(30~60)min;手术时间平均110(90~180)min;平均失血量150(80~400)ml。结石一次取净21例,1例残余结石,术后2个月带双J管行ESWL碎石排出。术后1~2月复查肾功能,术前有肾功能损害的8例,血清Cr平均110.2μmol/L,血清BUN平均8.0mmol/L,均明显改善,其余患者肾功能无损害,无严重术后并发症。18例随访6个月~3年无一例复发。结论原位低温阻断肾血管肾实质切开取石术治疗复杂性肾结石安全有效、出血少、结石残留率低。 相似文献
103.
不同剂量环孢素A对肾移植病人精液质量的影响 总被引:3,自引:3,他引:0
目的 :探讨不同治疗剂量环孢素A(CsA)对肾移植病人精液主要参数和精子形态学的影响。 方法 :对 18例应用不同治疗剂量CsA的肾移植病人的精液进行主要参数和精子形态学分析 ,并与 12例正常男性精液进行比较。 结果 :CsA剂量在 1.5~ 3.0mg·Kg-1·d-1及 3.1~ 5 .5mg·Kg-1·d-1时 ,病人精液的主要参数与正常男性精液比较差异无显著性 (P >0 .0 5 ) ,但病人正常形态精子百分率与正常男性相比差异有显著性 (P <0 .0 5 )。结论 :不同治疗剂量的CsA对肾移植病人的精液主要参数无明显影响 ,但对精子形态可能有一定的影响。 相似文献
104.
The antiviral agent foscarnet has long been used in our unit to treat cytomegalovirus (CMV) infections in renal transplant
patients. The clinical effect has been convincing and, apart from changes in serum calcium levels, very few side effects have
been noted. We have, however, observed a nephrotoxic reaction in a series of patients with initially good renal function who
therefore received high doses of foscarnet. Transplant biopsies performed in five of those patients revealed degenerative
changes in the tubular epithelial cells as well as tubular calcium deposits and an infiltration of the interstitium by mixed
mononuclear and polymorphonuclear leucocytes. Renal insufficiency was accompanied by high fever. After withdrawal of the drug,
the temperature rapidly normalized, whereas serum creatinine continued to rise for about 3 days and then fell back towards
previous levels. We conclude that transplant biopsies are of great value in distinguishing between a foscarnet nephrotoxic
effect and CMV nephritis, various forms of rejection, and other causes of impaired renal function. 相似文献
105.
Michel Broyer Geneviève Guest Marie-France Gagnadoux Daniel Beurton 《Pediatric nephrology (Berlin, Germany)》1987,1(1):16-21
The files of 334 consecutive cadaver kidney (CK) and of 27 living related (LR) transplantations (T) in children and adolescents performed from 1973 to 1984 have been reviewed. Following cadaver transplantation, 52 patients (15%) never had hypertension (HT), 41 patients (12%) had only initial HT up to 6 months after transplantation and 18 other patients (5%) exhibited transient HT episodes while on high-dose steroid therapy. Finally, 209 patients (62%) had HT for periods longer than 6 months and 16 patients (5%) until death or graft failure within the first 3 months. Chronic graft rejection was the major cause of HT, but other factors either isolated or in association were also present. Renal artery stenosis (RAS) was diagnosed in 43 cases (13%) 2–17 months post-transplantation; 10 of these were operated upon (5 successfully) and 9 underwent transluminal angioplasty with a single success. Nine cases of RAS resolved spontaneously. HT was attributed to the host kidney in 10 cases (3%) and to recurrence of primary renal disease in 9 (3%). HT observed after CKT was sometimes severe and difficult to control. Acute complications from HT were recorded in 35 cases, with 6 deaths and 2 severe neurological sequelae. Among 25 LRT, 11 cases (40%) had no HT 13 (48%) had HT for longer than 6 months. In this group, no case of RAS was observed and only one complication (without sequelae) was noted. In conclusion, HT is a frequent and sometimes severe complication post-transplantation in children and adolescents. 相似文献
106.
S. Ohsaki S. Teraoka T. Tojimbara K. Takahasi H. Toma T. Agishi K. Ota 《Transplant international》1992,5(Z1):S100-S103
Prostaglandin E1 (PGE1) was used in renal transplant recipients with living related donors. The drug was given intravenously from day 1 to day 7 after transplantation at a dose of 40 µg/kg twice a day. A total of 45 patients were studied divided into two groups: 25 patients were treated with PGE1 (group B) and the remaining 20 patients did not receive the drug (group A). In group B, 24-h creatinine clearance (Ccr) was 66 ± 12.8 ml/min compared with 40.3 ± 13.4 ml/min in group A on the fifth postoperative day (P < 0.05). Urinary levels of N-acetyl-β-d -glucosaminidase (NAG) and serum levels of platelet factor 4 (PF4) in group B were significantly lower than in group A. On the fourth postoperative day, the urinary excretion of thromboxan B2 (TxB2) in group A was higher than in group B, but not significantly (5.1 ± 3.0 ng/day and 2.8 ± 1.1 ng/day, respectively). Acute rejection occurred in four patients in group B and in 10 patients (40%) in group A. The percentage of Leu2a-positive lymphocytes in group B was higher than in group A. We conclude that postoperative administration of PGE1 improves graft function in kidneys from living related donors. 相似文献
107.
目的 探讨体外循环 (CPB)中应用乌司他丁 (UTI)对机体肾脏的影响。方法 择期CPB下心内直视术 40例 (ASAⅡ~Ⅲ级 )分为 2组 :乌司他丁组 (U组 ,n =2 0 ) ,于麻醉后、CPB开始前将UTI 2 0万U溶于 2 0ml 0 9%生理盐水中静脉注射 (约 10min) ;若CPB时间超过 4h ,可在CPB开始 4h后追加 1次 ,剂量方法同前。对照组 (C组 ,n =2 0 )不用UTI。分别于麻醉前及CPB结束 3h后检测血Bun、Cr及尿NAG、RBP、α1-MG、γ -GTP ,统计尿量并计算排尿量 /输液量。结果 麻醉前 :两组病人间血Bun、Cr和尿NAG、RBP、α1-MG、γ -GTP及排尿量均无显著性差异 (P >0 0 5 )。CPB结束后 :⑴两组病人其尿γ -GTP、NAG均分别高于麻醉前( P <0 0 5 ) ,但U组二者均分别低于C组 ( P <0 0 5 )。⑵两组病人其尿RBP、α1-MG均分别明显高于麻醉前 ( P <0 0 1) ,但U组二者分别低于C组 (P <0 0 5 )。⑶两组病人其排尿量均明显多于麻醉前 (P <0 0 1) ,但U组高于C组 (P <0 0 5 )。⑷U组病人其排尿量 /输液量高于C组 (P <0 0 5 )。结论 UTI对CPB下心内直视病人的肾脏功能有较强的保护作用 相似文献
108.
同种肾组织移植治疗慢性肾功能衰竭性贫血的实验研究 总被引:4,自引:0,他引:4
以Wistar雄性大鼠为受体,建立慢性肾功能衰竭动物模型,将鼠婴肾组织声多点植入受体双侧后肢皮下和筋膜下。结果表明,30天后移植物的体积由1mm^3增至4mm^3大小,表面血管网丰富;光镜下见肾小球、肾小管结构正常。促红细胞生成素(EPO)着色颗粒主要分布在肾小球区,移植组着色程度明显增高。血红蛋白和4促红细胞生成素随移植的时间延长而逐渐升高,实验结果提示,此方法有可能为治疗慢性肾功能衰竭性贫血提 相似文献
109.
D. Dickerson B. Adams G. Engelbrecht G. Boltman R. Hickman D. Kahn 《Transplant international》1992,5(Z1):S63-S64
The precise cause of allograft dysfunction after renal transplantation often cannot be established by non-invasive means. In clinical practice, radionuclide scans form an integral part of the clinician's armamentarium in the assessment of these patients [1, 2]. Unfortunately, in the clinical setting more than one pathological process may be responsible for the impaired function, making it difficult to correlate the scan appearances with the pathology. In this study in rats we compared the renal DTPA scan appearances of the various pathological processes which may cause renal allograft dysfunction in the immediate post-transplant period. 相似文献
110.
Summary
Extracorporeal shock wave lithotripsy (ESWL) is standard therapy for urolithiasis. With comparable technical principles, various
lithotripters have been developed and are in routine use. Renal pelvic stones, calyceal stones, ureteral stones, and other
special forms can be treated with varying results. Currently, the so-called clinically insignificant residual fragments and
the recurrence of calculi are under discussion. Whereas the side effects of ESWL are well known, studies comparing ESWL with
other endourological procedures are still lacking.
相似文献